Pfizer to allow generic version of COVID-19 pill
Pfizer said it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool.
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook